Cargando…

A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis

BACKGROUND: The success of programs to eliminate lymphatic filariasis (LF) depends in large part on their ability to achieve and sustain high levels of compliance with mass drug administration (MDA). This paper reports results from a comprehensive review of factors that affect compliance with MDA. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Krentel, Alison, Fischer, Peter U., Weil, Gary J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836848/
https://www.ncbi.nlm.nih.gov/pubmed/24278486
http://dx.doi.org/10.1371/journal.pntd.0002447
_version_ 1782292356413784064
author Krentel, Alison
Fischer, Peter U.
Weil, Gary J.
author_facet Krentel, Alison
Fischer, Peter U.
Weil, Gary J.
author_sort Krentel, Alison
collection PubMed
description BACKGROUND: The success of programs to eliminate lymphatic filariasis (LF) depends in large part on their ability to achieve and sustain high levels of compliance with mass drug administration (MDA). This paper reports results from a comprehensive review of factors that affect compliance with MDA. METHODOLOGY/PRINCIPAL FINDINGS: Papers published between 2000 and 2012 were considered, and 79 publications were included in the final dataset for analysis after two rounds of selection. While results varied in different settings, some common features were associated with successful programs and with compliance by individuals. Training and motivation of drug distributors is critically important, because these people directly interact with target populations, and their actions can affect MDA compliance decisions by families and individuals. Other important programmatic issues include thorough preparation of personnel, supplies, and logistics for implementation and preparation of the population for MDA. Demographic factors (age, sex, income level, and area of residence) are often associated with compliance by individuals, but compliance decisions are also affected by perceptions of the potential benefits of participation versus the risk of adverse events. Trust and information can sometimes offset fear of the unknown. While no single formula can ensure success MDA in all settings, five key ingredients were identified: engender trust, tailor programs to local conditions, take actions to minimize the impact of adverse events, promote the broader benefits of the MDA program, and directly address the issue of systematic non-compliance, which harms communities by prolonging their exposure to LF. CONCLUSIONS/SIGNIFICANCE: This review has identified factors that promote coverage and compliance with MDA for LF elimination across countries. This information may be helpful for explaining results that do not meet expectations and for developing remedies for ailing MDA programs. Our review has also identified gaps in understanding and suggested priority areas for further research.
format Online
Article
Text
id pubmed-3836848
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-38368482013-11-25 A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis Krentel, Alison Fischer, Peter U. Weil, Gary J. PLoS Negl Trop Dis Review BACKGROUND: The success of programs to eliminate lymphatic filariasis (LF) depends in large part on their ability to achieve and sustain high levels of compliance with mass drug administration (MDA). This paper reports results from a comprehensive review of factors that affect compliance with MDA. METHODOLOGY/PRINCIPAL FINDINGS: Papers published between 2000 and 2012 were considered, and 79 publications were included in the final dataset for analysis after two rounds of selection. While results varied in different settings, some common features were associated with successful programs and with compliance by individuals. Training and motivation of drug distributors is critically important, because these people directly interact with target populations, and their actions can affect MDA compliance decisions by families and individuals. Other important programmatic issues include thorough preparation of personnel, supplies, and logistics for implementation and preparation of the population for MDA. Demographic factors (age, sex, income level, and area of residence) are often associated with compliance by individuals, but compliance decisions are also affected by perceptions of the potential benefits of participation versus the risk of adverse events. Trust and information can sometimes offset fear of the unknown. While no single formula can ensure success MDA in all settings, five key ingredients were identified: engender trust, tailor programs to local conditions, take actions to minimize the impact of adverse events, promote the broader benefits of the MDA program, and directly address the issue of systematic non-compliance, which harms communities by prolonging their exposure to LF. CONCLUSIONS/SIGNIFICANCE: This review has identified factors that promote coverage and compliance with MDA for LF elimination across countries. This information may be helpful for explaining results that do not meet expectations and for developing remedies for ailing MDA programs. Our review has also identified gaps in understanding and suggested priority areas for further research. Public Library of Science 2013-11-21 /pmc/articles/PMC3836848/ /pubmed/24278486 http://dx.doi.org/10.1371/journal.pntd.0002447 Text en © 2013 Krentel et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Review
Krentel, Alison
Fischer, Peter U.
Weil, Gary J.
A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis
title A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis
title_full A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis
title_fullStr A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis
title_full_unstemmed A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis
title_short A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis
title_sort review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3836848/
https://www.ncbi.nlm.nih.gov/pubmed/24278486
http://dx.doi.org/10.1371/journal.pntd.0002447
work_keys_str_mv AT krentelalison areviewoffactorsthatinfluenceindividualcompliancewithmassdrugadministrationforeliminationoflymphaticfilariasis
AT fischerpeteru areviewoffactorsthatinfluenceindividualcompliancewithmassdrugadministrationforeliminationoflymphaticfilariasis
AT weilgaryj areviewoffactorsthatinfluenceindividualcompliancewithmassdrugadministrationforeliminationoflymphaticfilariasis
AT krentelalison reviewoffactorsthatinfluenceindividualcompliancewithmassdrugadministrationforeliminationoflymphaticfilariasis
AT fischerpeteru reviewoffactorsthatinfluenceindividualcompliancewithmassdrugadministrationforeliminationoflymphaticfilariasis
AT weilgaryj reviewoffactorsthatinfluenceindividualcompliancewithmassdrugadministrationforeliminationoflymphaticfilariasis